World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN (O) : 2455-3301
ISSN (P) : 3051-2557
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , Doi-Digital Online Identifier , ISSN National Centre , 

Abstract

A COMPREHENSIVE AYURVEDIC APPROACH TO MANAGING CHRONIC KIDNEY DISEASE (VRIKKA VIKARA) AND CHOLELITHIASIS: A CASE REPORT

Acharya Manish, Dr. Gitika Chaudhary*, Dr. Richa, Dr. Rishabh, Dr. Tanu Rani

ABSTRACT

This case report discusses the comprehensive management of chronic kidney disease (CKD) in a 70-year-old female patient, encompassing an integrated approach of conventional and alternative treatments. Initially presenting with significant symptoms including reduced urine output, stomach pain, dizziness, memory decline, and joint pain, the patient's condition posed various therapeutic challenges. Over the course of treatment, notable improvements were observed: serum creatinine levels were reduced from 3.6 mg/dl to 1.75 mg/dl and blood urea levels decreased from 98 mg/dl to 48.9 mg/dl. Subjective improvements were equally significant, with a reduction in pain severity from a score of 7 to 3 on the Visual Analogue Scale (VAS) and an increase in cognitive function scores from 20 to 24 on the Mini-Mental State Examination (MMSE). The treatment protocols included a combination of dietary adjustments, lifestyle modifications, and therapeutic interventions that targeted both the symptoms and underlying pathophysiological mechanisms of CKD. The follow-up outcomes underscore the effectiveness of the integrated treatment approach in managing CKD symptoms and enhancing the patient's quality of life, illustrating the potential for broader application in similar clinical scenarios.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR